Zevra Therapeutics Stock Zoomed: Why the 21% Jump Happened
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Compare safety profiles of hot versus cold wallets and learn best practices to keep your funds secure in daily use.
20,484 articlesZevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Evergreen demand makes certain stocks thrive through booms and busts. Learn how these consumer staples stocks stay re...
A federal judge halted DOJ subpoenas tied to Powell’s June testimony about a $2.5 billion renovation, delivering a se...
As Nvidia captures headlines with its chips, two AI software plays are quietly building durable demand. This article ...
If you have $500 to invest in AI, you don’t need to chase hot picks. The smarter move is a diversified AI ETF with a ...
Three growth-focused ETFs have fallen this month as rates move and leadership shifts unsettle risk assets. One fund s...
Middleby Corp. launches its most sweeping restructuring in years, slimming the portfolio to focus on core, higher-mar...
Iran signals a selective pass-through policy at the Strait of Hormuz, potentially tightening oil flows and boosting m...
As software shares pull back in 2026, you don’t have to chase chaos. This article identifies one software stock actua...
Advantage (ADV) stunned some on the street with the Q2 2025 numbers, while others saw a path to steady growth. This d...
The AI boom isn’t over yet, according to seasoned investor Paul Tudor Jones Says. This piece breaks down why the rall...
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...